What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Myocardial infarction
- Cardiology
His main research concerns Internal medicine, Cardiology, Myocardial infarction, Endocrinology and Percutaneous coronary intervention.
His work carried out in the field of Internal medicine brings together such families of science as Diabetes mellitus, Placebo and Surgery.
The concepts of his Cardiology study are interwoven with issues in Stroke and Thrombosis.
His Myocardial infarction study incorporates themes from Gastroenterology, Cohort study and Confidence interval.
His research integrates issues of Thrombomodulin and Polyunsaturated fatty acid in his study of Endocrinology.
Harald Arnesen interconnects Ejection fraction, Conventional PCI, Acute coronary syndrome, Anterior Descending Coronary Artery and Autologous stem-cell transplantation in the investigation of issues within Percutaneous coronary intervention.
His most cited work include:
- Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction. (1200 citations)
- Warfarin, aspirin, or both after myocardial infarction (664 citations)
- The effect of warfarin on mortality and reinfarction after myocardial infarction. (552 citations)
What are the main themes of his work throughout his whole career to date?
Internal medicine, Cardiology, Myocardial infarction, Endocrinology and Coronary artery disease are his primary areas of study.
Harald Arnesen has included themes like Diabetes mellitus, Gastroenterology and Surgery in his Internal medicine study.
His Ejection fraction, Heart failure and Troponin T study in the realm of Cardiology interacts with subjects such as In patient.
His Myocardial infarction research is multidisciplinary, relying on both Stroke, Aspirin, Randomized controlled trial and Warfarin.
His Warfarin research incorporates themes from Anticoagulant and Anesthesia.
The various areas that Harald Arnesen examines in his Endocrinology study include Inflammation and Polyunsaturated fatty acid.
He most often published in these fields:
- Internal medicine (107.83%)
- Cardiology (61.98%)
- Myocardial infarction (47.93%)
What were the highlights of his more recent work (between 2015-2021)?
- Internal medicine (107.83%)
- Cardiology (61.98%)
- Myocardial infarction (47.93%)
In recent papers he was focusing on the following fields of study:
His scientific interests lie mostly in Internal medicine, Cardiology, Myocardial infarction, Coronary artery disease and Diabetes mellitus.
When carried out as part of a general Internal medicine research project, his work on Heart failure is frequently linked to work in In patient, therefore connecting diverse disciplines of study.
Many of his studies on Cardiology involve topics that are commonly interrelated, such as CAD.
His biological study spans a wide range of topics, including Stroke, Polyunsaturated fatty acid, Clinical endpoint and Neutrophil extracellular traps.
His studies deal with areas such as Inflammation, Randomized controlled trial, Pathology, Venous blood and Stenosis as well as Coronary artery disease.
His work deals with themes such as Adipose tissue, Endothelial activation, Disease and Endothelial dysfunction, which intersect with Diabetes mellitus.
Between 2015 and 2021, his most popular works were:
- Platelet-, monocyte-derived and tissue factor-carrying circulating microparticles are related to acute myocardial infarction severity (43 citations)
- Platelet-, monocyte-derived and tissue factor-carrying circulating microparticles are related to acute myocardial infarction severity (43 citations)
- Circulating Levels of IL‐6 Receptor and gp130 and Long‐Term Clinical Outcomes in ST‐Elevation Myocardial Infarction (31 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Myocardial infarction
- Cardiology
Harald Arnesen mainly focuses on Internal medicine, Myocardial infarction, Cardiology, Coronary artery disease and Gastroenterology.
His Internal medicine study frequently draws connections between related disciplines such as Type 2 diabetes.
His Myocardial infarction study integrates concerns from other disciplines, such as Neutrophil extracellular traps, Docosahexaenoic acid, Polyunsaturated fatty acid, Fatty acid and Stroke.
As part of the same scientific family, Harald Arnesen usually focuses on Cardiology, concentrating on Hazard ratio and intersecting with Ventricular remodeling.
His Coronary artery disease research integrates issues from Diabetes mellitus, Endocrinology, Von Willebrand factor and Pathology.
Within one scientific family, Harald Arnesen focuses on topics pertaining to Immunology under Gastroenterology, and may sometimes address concerns connected to Aspirin.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
